Please login to the form below

Not currently logged in
Email:
Password:

New accounts: January

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October to Novemeber 2005 inclusive
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October to Novemeber 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com

 

GlaxoSmithKline

Cervarix

Cervical cancer (consumer healthcare)

Clew Communications

GrÈnenthal

New product launch

N/A

Jango Communications

Haemophilia Society

N/A

Corporate

Red Door Communications

LiDCO

LiDCO

Intensive care medicine

Reynolds-MacKenzie

Novartis

Exjade

Sickle cell disease

Avenue

Novartis

Glivec

Oncology - GIST

Avenue

Novartis

Transplantation portfolio

Transplantation

LeapFrog Medical

Pfizer

Injectable contraceptive

Contraception

Ruder Finn

Procter & Gamble

Asacol

Inflammatory bowel disease

Resolute Communications

Roche

Avastin

Oncology

Ketchum

Solvay

Omacor

Cardiology

LeapFrog Medical

2nd September 2008

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Main image2
Customers, content and change
By Dominic Tyer...
Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...